One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts

96
43
Favorite

One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts

cnbc2021-06-15

As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally. “The Nasdaq Composite broadly is breaking higher, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（43）

SPOT_ON
·2021-06-16
Nice
Reply
2
Report
Rewn
·2021-06-16
Nice
Reply
1
Report
求老师指点
·2021-06-16
Thank you
Reply
Like
Report
Murphy57
·2021-06-16
Comment and like
Reply
Like
Report
whyisofat
·2021-06-16
This is important
Reply
1
Report
kj1234
·2021-06-15
Interesting
Reply
Like
Report
starrys
·2021-06-15
Healthcare is stable buy in all market conditions
Reply
Like
Report
Fold Replies
- Nagoken:
  Sure
  2021-06-15
  Reply
  Report
Starrynight
·2021-06-15
[Strong]
Reply
Like
Report
Fold Replies
- Nagoken:
  Hello
  2021-06-15
  Reply
  Report
mitaking
·2021-06-15
Thanks
Reply
Like
Report
Yukago
·2021-06-15
Oh dear!
Reply
Like
Report
Fatboiiiswim
·2021-06-15
Thanks
Reply
Like
Report
shawnyprawny
·2021-06-15
Ok
Reply
Like
Report
Jlenglui
·2021-06-15
You
Reply
4
Report
Fold Replies
- Pjun:
  ok
  2021-06-16
  Reply
  Report
BEEBOOOO
·2021-06-15
Please like and comment
Reply
4
Report
Fold Replies
- Sushiroll:
  Same Please
  2021-06-15
  Reply
  Report
HengHengUp
·2021-06-15
Hello
Reply
2
Report
Fold Replies
- Jaslen:
  Hello! Reply please thanks!
  2021-06-15
  Reply
  Report
Lucky_jk
·2021-06-15
Good!!
Reply
4
Report
Fold Replies
- Lucky_jk:
  Yes.
  2021-06-15
  Reply
  Report
- BigMan:
  nice.
  2021-06-15
  Reply
  Report
ShinYi
·2021-06-15
Nice
Reply
Like
Report
DLJR
·2021-06-15
Wow
Reply
Like
Report
smoldino
·2021-06-15
Oooo
Reply
Like
Report
AtwoZ
·2021-06-15
Good
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1156005756?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-15 19:30","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1156005756","market":"us","top_or_hot":-1,"title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","media":"cnbc","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Source Link</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IBB","symbol_name":"生物科技指数ETF-iShares Nasdaq","start_time":0,"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","article_id":"1156005756","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","pubTimestamp":1623756623,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IBB":"生物科技指数ETF-iShares Nasdaq","ABBV":"艾伯维公司","JNJ":"强生","BIIB":"渤健公司","AMGN":"安进"},"translate_title":"Oppenheimer分析师预测，医疗保健行业的一个角落可能引领纳斯达克下一轮创纪录的上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9,"AMGN":0.9,"BIIB":0.9,"IBB":0.9,"JNJ":0.9},"content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":160641673,"gmtCreate":1623797734192,"gmtModify":1703819488579,"author":{"id":"3582922989777578","authorId":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1,"idStr":"3582922989777578","authorIdStr":"3582922989777578"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160641673","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160687379,"gmtCreate":1623795827091,"gmtModify":1703819442200,"author":{"id":"3582013538866054","authorId":"3582013538866054","name":"Rewn","avatar":"https://static.tigerbbs.com/7e085a740a2e75b83b9cc2373d01a7f3","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582013538866054","authorIdStr":"3582013538866054"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160687379","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160168228,"gmtCreate":1623775246064,"gmtModify":1703819184250,"author":{"id":"3574409130628325","authorId":"3574409130628325","name":"求老师指点","avatar":"https://static.tigerbbs.com/9f37c6fe3f11098991d08587e5b22a23","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574409130628325","authorIdStr":"3574409130628325"},"htmlText":"Thank you","listText":"Thank you","text":"Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160168228","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160163191,"gmtCreate":1623775153613,"gmtModify":1703819181824,"author":{"id":"3573776797513693","authorId":"3573776797513693","name":"Murphy57","avatar":"https://static.tigerbbs.com/4a0040def4d40f2d6fe3090a480b7d44","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573776797513693","authorIdStr":"3573776797513693"},"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160163191","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160180535,"gmtCreate":1623774792527,"gmtModify":1703819166429,"author":{"id":"3581683443282525","authorId":"3581683443282525","name":"whyisofat","avatar":"https://static.tigerbbs.com/976e382b54c0eeb307ced328f342b2b9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581683443282525","authorIdStr":"3581683443282525"},"htmlText":"This is important","listText":"This is important","text":"This is important","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160180535","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160946877,"gmtCreate":1623770655799,"gmtModify":1703818957791,"author":{"id":"3586863446702582","authorId":"3586863446702582","name":"kj1234","avatar":"https://static.tigerbbs.com/d429c1d423b4f758c14e073337450edc","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586863446702582","authorIdStr":"3586863446702582"},"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160946877","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160005553,"gmtCreate":1623765753572,"gmtModify":1703818712461,"author":{"id":"3555306185724245","authorId":"3555306185724245","name":"starrys","avatar":"https://static.tigerbbs.com/c5fdf02892a55030cf24ff3c4a3678c0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3555306185724245","authorIdStr":"3555306185724245"},"htmlText":"Healthcare is stable buy in all market conditions","listText":"Healthcare is stable buy in all market conditions","text":"Healthcare is stable buy in all market conditions","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/160005553","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4781235,"gmtCreate":1623766955667,"gmtModify":1663228896633,"authorId":3576560237263785,"author":{"id":3576560237263785,"idStr":"3576560237263785","authorId":3576560237263785,"name":"Nagoken","avatar":"https://static.tigerbbs.com/caac3ac5db4b0d37985b9f55a62d569f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":160005553,"type":1,"supId":0,"prevId":0,"content":"<u>Sure</u>","text":"<u>Sure</u>","html":"<u>Sure</u>"}],"langContent":"EN"},{"id":187750952,"gmtCreate":1623765048376,"gmtModify":1703818658122,"author":{"id":"3586800400969116","authorId":"3586800400969116","name":"Starrynight","avatar":"https://static.tigerbbs.com/68b69d7ca8c1b19556150b91c1e4fc50","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586800400969116","authorIdStr":"3586800400969116"},"htmlText":"[Strong]&nbsp;","listText":"[Strong]&nbsp;","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/187750952","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4781250,"gmtCreate":1623766977202,"gmtModify":1663228898344,"authorId":3576560237263785,"author":{"id":3576560237263785,"idStr":"3576560237263785","authorId":3576560237263785,"name":"Nagoken","avatar":"https://static.tigerbbs.com/caac3ac5db4b0d37985b9f55a62d569f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187750952,"type":1,"supId":0,"prevId":0,"content":"<u>Hello</u>","text":"<u>Hello</u>","html":"<u>Hello</u>"}],"langContent":"EN"},{"id":187732849,"gmtCreate":1623764220181,"gmtModify":1703818597784,"author":{"id":"3580692426790646","authorId":"3580692426790646","name":"mitaking","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580692426790646","authorIdStr":"3580692426790646"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187732849","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187795196,"gmtCreate":1623764033715,"gmtModify":1703818584904,"author":{"id":"3579429917054455","authorId":"3579429917054455","name":"Yukago","avatar":"https://static.tigerbbs.com/eecb68d10d332e20ee23f1e84c574bb7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579429917054455","authorIdStr":"3579429917054455"},"htmlText":"Oh dear!","listText":"Oh dear!","text":"Oh dear!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187795196","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187473495,"gmtCreate":1623763458417,"gmtModify":1703818548935,"author":{"id":"3586472874126808","authorId":"3586472874126808","name":"Fatboiiiswim","avatar":"https://static.tigerbbs.com/92f9cd11969c2a60eb3c22f778b1991a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586472874126808","authorIdStr":"3586472874126808"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187473495","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187421409,"gmtCreate":1623762553101,"gmtModify":1703818508724,"author":{"id":"3575333732561920","authorId":"3575333732561920","name":"shawnyprawny","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3575333732561920","authorIdStr":"3575333732561920"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187421409","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187487863,"gmtCreate":1623762092952,"gmtModify":1703818489250,"author":{"id":"3579491276699992","authorId":"3579491276699992","name":"Jlenglui","avatar":"https://static.tigerbbs.com/dbbf978ba7471629b0f6a72b1497fce4","vip":2,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":6,"crmLevelSwitch":1,"idStr":"3579491276699992","authorIdStr":"3579491276699992"},"htmlText":"You","listText":"You","text":"You","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/187487863","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4785292,"gmtCreate":1623773713118,"gmtModify":1663228915731,"authorId":3568112587764186,"author":{"id":3568112587764186,"idStr":"3568112587764186","authorId":3568112587764186,"name":"Pjun","avatar":"https://static.tigerbbs.com/8cfe0a02203e702b7aae055eaa9823be","vip":1,"crmLevel":7,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187487863,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":187485198,"gmtCreate":1623762029314,"gmtModify":1703818486330,"author":{"id":"3581743788219336","authorId":"3581743788219336","name":"BEEBOOOO","avatar":"https://static.tigerbbs.com/1784fc46c37088fbdc7501227130bc27","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581743788219336","authorIdStr":"3581743788219336"},"htmlText":"Please like and comment&nbsp;","listText":"Please like and comment&nbsp;","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/187485198","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4778227,"gmtCreate":1623762604409,"gmtModify":1663228884037,"authorId":3582274633297304,"author":{"id":3582274633297304,"idStr":"3582274633297304","authorId":3582274633297304,"name":"Sushiroll","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187485198,"type":1,"supId":0,"prevId":0,"content":"Same Please","text":"Same Please","html":"Same Please"}],"langContent":"EN"},{"id":187435816,"gmtCreate":1623761534635,"gmtModify":1703818456400,"author":{"id":"3581681950956680","authorId":"3581681950956680","name":"HengHengUp","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581681950956680","authorIdStr":"3581681950956680"},"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/187435816","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4777784,"gmtCreate":1623761981391,"gmtModify":1663228880974,"authorId":3579319144921544,"author":{"id":3579319144921544,"idStr":"3579319144921544","authorId":3579319144921544,"name":"Jaslen","avatar":"https://static.tigerbbs.com/597ef08fd8f2bd857b8021d7044cd65a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187435816,"type":1,"supId":0,"prevId":0,"content":"Hello! Reply please thanks!","text":"Hello! Reply please thanks!","html":"Hello! Reply please thanks!"}],"langContent":"EN"},{"id":187435087,"gmtCreate":1623761517949,"gmtModify":1703818455583,"author":{"id":"3582019013174479","authorId":"3582019013174479","name":"Lucky_jk","avatar":"https://static.tigerbbs.com/e6bb76d91ce80402431f828f4950d954","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582019013174479","authorIdStr":"3582019013174479"},"htmlText":"Good!!","listText":"Good!!","text":"Good!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/187435087","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4777849,"gmtCreate":1623762033441,"gmtModify":1663228883234,"authorId":3582019013174479,"author":{"id":3582019013174479,"idStr":"3582019013174479","authorId":3582019013174479,"name":"Lucky_jk","avatar":"https://static.tigerbbs.com/e6bb76d91ce80402431f828f4950d954","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187435087,"type":1,"supId":4777714,"prevId":0,"content":"Yes.","text":"Yes.","html":"Yes."},{"id":4777714,"gmtCreate":1623761899973,"gmtModify":1663228881330,"authorId":3582627631616249,"author":{"id":3582627631616249,"idStr":"3582627631616249","authorId":3582627631616249,"name":"BigMan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187435087,"type":1,"supId":0,"prevId":0,"content":"nice.","text":"nice.","html":"nice."}],"langContent":"EN"},{"id":187432891,"gmtCreate":1623761504413,"gmtModify":1703818455093,"author":{"id":"3576616662229317","authorId":"3576616662229317","name":"ShinYi","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3576616662229317","authorIdStr":"3576616662229317"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187432891","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187576487,"gmtCreate":1623760597649,"gmtModify":1703818409515,"author":{"id":"3580014250006616","authorId":"3580014250006616","name":"DLJR","avatar":"https://static.tigerbbs.com/b616730490b2660a1473a9b7751872a4","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":4,"crmLevelSwitch":0,"idStr":"3580014250006616","authorIdStr":"3580014250006616"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187576487","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187545514,"gmtCreate":1623760377338,"gmtModify":1703818397886,"author":{"id":"3583658985776486","authorId":"3583658985776486","name":"smoldino","avatar":"https://static.tigerbbs.com/686466b727e054e2724d48291ae00308","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583658985776486","authorIdStr":"3583658985776486"},"htmlText":"Oooo","listText":"Oooo","text":"Oooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187545514","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187546367,"gmtCreate":1623760318159,"gmtModify":1703818395087,"author":{"id":"3586254379286032","authorId":"3586254379286032","name":"AtwoZ","avatar":"https://static.tigerbbs.com/7347da48f4f74369b5ff3a53a2e36a45","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586254379286032","authorIdStr":"3586254379286032"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187546367","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://ttm.financial/m/news/1156005756?lang=&edition=fundamental","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","ABBV":"艾伯维公司","JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":96,"commentSize":43,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}